The impact of specific viruses on clinical outcome in children presenting with acute heart failure

International Journal of Molecular Sciences

Volumn 17, Issue 4, 2016, Pages 1-10

  Gagliardi, Maria Giulia ^a   Fierabracci, Alessandra ^a   Pilati, Mara ^a   Chinali, Marcello ^a   Bassano, Carlo ^b   Saura, Francesca ^a   Giovannoni, Isabella ^a   Francalanci, Paola ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biopsy; Cardiomyopathy; Echocardiography; Longitudinal study; Myocarditis; Pediatric; Virus

Indexed keywords

ACUTE HEART FAILURE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; HUMAN PARVOVIRUS B19; INFANT; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NONHUMAN; POLYMERASE CHAIN REACTION; POST HOC ANALYSIS; PROGNOSIS; VIRUS; VIRUS GENOME; ACUTE DISEASE; BIOPSY; CARDIAC MUSCLE; CARDIOMYOPATHY, DILATED; COMPLICATION; GENETICS; HEART; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; METABOLISM; MORTALITY; PARVOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; VIROLOGY; YOUNG ADULT;

VIRUS DNA;

ACUTE DISEASE; ADOLESCENT; BIOPSY; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEART; HEART FAILURE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MYOCARDITIS; MYOCARDIUM; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84962367322     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17040486     Document Type: Article

References (33)

1. Kühl, U.; Schultheiss, H.P. Myocarditis in children. Heart Fail. Clin. 2010, 6, 483-496. [CrossRef] [PubMed]
2. Rose, N.R. Myocarditis: Infection versus autoimmunity. J. Clin. Immunol. 2009, 29, 730-737. [CrossRef] [PubMed]
3. Baboonian, C.; Treasure, T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997, 78, 539-543. [CrossRef] [PubMed]
4. Pollack, A.; Kontorovich, A.R.; Fuster, V.; Dec, G.W. Viral myocarditis-diagnosis, treatment, options, and current controversies. Nat. Rev. Cardiol. 2015, 12, 670-680. [CrossRef] [PubMed]
5. Friedrich, M.G.; Marcotte, F. Cardiac magnetic resonance assessment of myocarditis. Circ. Cardiovasc. Imaging 2013, 6, 833-839. [CrossRef] [PubMed]
6. Cooper, L.T.; Baughman, K.L.; Feldman, A.M.; Frustaci, A.; Jessup, M.; Kuhl, U.; Levine, G.N.; Narula, J.; Starling, R.C.; Towbin, J.; et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J. Am. Coll. Cardiol. 2007, 50, 1914-1931. [PubMed]
7. Magnani, J.W.; Danik, H.J.; Dec, G.W., Jr.; di Salvo, T.G. Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am. Heart J. 2006, 151, 463-470. [CrossRef] [PubMed]
8. Bowles, N.E.; Richardson, P.J.; Olsen, E.G.; Archard, L.C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986, 1, 1120-1123. [CrossRef]
9. Why, H.J.; Meany, B.T.; Richardson, P.J.; Olsen, E.G.; Bowles, N.E.; Cunningham, L.; Freeke, C.A.; Archard, L.C. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994, 89, 2582-2589. [CrossRef] [PubMed]
10. Bowles, N.E.; Ni, J.; Kearney, D.L.; Pauschinger, M.; Schultheiss, H.P.; McCarthy, R.; Hare, J.; Bricker, J.T.; Bowles, K.R.; Towbin, J.A. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003, 42, 4664-4672. [CrossRef]
11. Salimans, M.M.; Holsappel, S.; van de Rijke, F.M.; Jiwa, N.M.; Raap, A.K.; Weiland, H.T. Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J. Virol. Methods 1989, 23, 19-28. [CrossRef]
12. Lotze, U.; Egerer, R.; Glück, B.; Zell, R.; Sigusch, H.; Erhardt, C.; Heim, A.; Kandolf, R.; Bock, T.;Wutzler, P.; et al. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. J. Med. Virol. 2010, 82, 1449-1457. [CrossRef] [PubMed]
13. Kandolf, R.; Ameis, D.; Kirschner, P.; Canu, A.; Hofschneider, P.H. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl. Acad. Sci. USA 1987, 84, 6272-6276. [CrossRef] [PubMed]
14. Schultz, J.C.; Hilliard, A.A.; Cooper, L.T., Jr.; Rihal, C.S. Diagnosis and treatment of viral myocarditis. Mayo Clin. Proc. 2009, 84, 1001-1009. [CrossRef]
15. Klein, R.M.; Jiang, H.; Niederacher, D.; Adams, O.; Du, M.; Horlitz, M.; Schley, P.; Marx, R.; Lankisch, M.R.; Brehm, M.U.; et al. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z. Kardiol. 2004, 93, 300-309. [PubMed]
16. Tschöpe, C.; Bock, C.T.; Kasner, M.; Noutsias, M.; Westermann, D.; Schwimmbeck, P.L.; Pauschinger, M.; Poller, W.C.; Kühl, U.; Kandolf, R.; et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005, 111, 879-886. [CrossRef] [PubMed]
17. Kühl, U.; Pauschinger, M.; Seeberg, B.; Lassner, D.; Noutsias, M.; Poller,W.; Schultheiss, H.P. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005, 112, 1965-1970. [CrossRef] [PubMed]
18. Bock, C.T.; Klingel, K.; Kandolf, R. Human parvovirus B19-associated myocarditis. N. Engl. J. Med. 2010, 362, 1248-1249. [CrossRef] [PubMed]
19. Schowengerdt, K.O.; Ni, J.; Denfield, S.W.; Gajarski, R.J.; Bowles, N.E.; Rosenthal, G.; Kearney, D.L.; Price, J.K.; Rogers, B.B.; Schauer, G.M.; et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997, 96, 3549-3554. [CrossRef] [PubMed]
20. Francalanci, P.; Chance, J.L.; Vatta, M.; Jimenez, S.; Li, H.; Towbin, J.A.; Bowles, N.E. Cardiotropic viruses in the myocardium of children with end-stage heart disease. J. Heart Lung Transplant. 2004, 23, 1046-1052. [CrossRef] [PubMed]
21. Aretz, H.T.; Billingham, M.E.; Edwards, W.D.; Factor, S.M.; Fallon, J.T.; Fenoglio, J.J., Jr.; Olsen, E.G.; Schoen, F.J. Myocarditis: A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1987, 1, 3-14. [PubMed]
22. Gagliardi, M.G.; Bevilacqua, M.; Bassano, C.; Leonardi, B.; Boldrini, R.; Camassei, F.D.; Fierabracci, A.; Ugazio, A.G.; Bottazzo, G.F. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004, 90, 1167-1171. [CrossRef] [PubMed]
23. Enders, G.; Dötsch, J.; Bauer, J.; Nützenadel, W.; Hengel, H.; Haffner, D.; Schalasta, G.; Searle, K.; Brown, K.E. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: Two case reports. Clin. Infect. Dis. 1998, 26, 355-358. [CrossRef] [PubMed]
24. Bowles, N.E.; Rose, M.L.; Taylor, P.; Banner, N.R.; Morgan-Capner, P.; Cunningham, L.; Archard, L.C.; Yacoub, M.H. End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 1989, 80, 1128-1136. [CrossRef] [PubMed]
25. Amabile, N.; Fraisse, A.; Bouvenot, J.; Chetaille, P.; Ovaert, C. Outcome of acute fulminant myocarditis in children. Heart 2006, 92, 1269-1273. [CrossRef] [PubMed]
26. Dina, J.; Villedieu, F.; Labombarda, F.; Chetaille, P.; Ovaert, C. Childhood myocarditis and parvovirus B19 genotypes. J. Clin. Virol. 2011, 50, 61-64. [CrossRef] [PubMed]
27. Molina, K.M.; Garcia, X.; Denfield, S.W.; Fan, Y.; Morrow, W.R.; Towbin, J.A.; Frazier, E.A.; Nelson, D.P. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr. Cardiol. 2013, 34, 390-397. [CrossRef] [PubMed]
28. Cohen, B.J.; Buckley, M.M. The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microbiol. 1988, 25, 151-153. [CrossRef] [PubMed]
29. Young, N.S.; Brown, K.E. Parvovirus B19. N. Engl. J. Med. 2004, 350, 586-597. [CrossRef] [PubMed]
30. Magro, C.M.; Crowson, A.N.; Dawood, M.; Nuovo, G.J. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune disease. J. Rheumatol. 2002, 29, 1227-1235. [PubMed]
31. Kühl, U.; Pauschinger, M.; Bock, T.; Klingel, K.; Schwimmbeck, C.P.; Seeberg, B.; Krautwurm, L.; Poller, W.; Schultheiss, H.P.; Kandolf, R. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003, 108, 945-950. [CrossRef] [PubMed]
32. Bültmann, B.D.; Klingel, K.; Sotlar, K.; Bock, C.T.; Baba, H.A.; Sauter, M.; Kandolf, R. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated disease. Hum. Pathol. 2003, 34, 92-95. [CrossRef] [PubMed]
33. Moulik, M.; Breinholt, J.P.; Dreyer, W.J.; Kearney, D.L.; Price, J.F.; Clunie, S.K.; Moffett, B.S.; Kim, J.J.; Rossano, J.W.; Jefferies, J.L.; et al. Viralendomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J. Am. Coll. Cardiol. 2010, 56, 582-592. [CrossRef] [PubMed